Analyst Price Targets — EPIX
Page 1 • Showing up to 10
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| November 4, 2024 8:54 am | Joseph Catanzaro | Piper Sandler | $2.00 | $1.63 | StreetInsider | Piper Sandler Downgrades ESSA Pharma (EPIX) to Neutral |
| September 16, 2024 7:56 am | Leland Gershell | Oppenheimer | $17.00 | $6.85 | StreetInsider | Oppenheimer Reiterates Outperform Rating on ESSA Pharma (EPIX) |
| September 16, 2024 7:48 am | Tyler Van Buren | Piper Sandler | $15.00 | $6.85 | StreetInsider | Piper Sandler Reiterates Overweight Rating on ESSA Pharma (EPIX) |
×
This site can’t be displayed in an embedded view
Some publishers block loading inside other sites for security reasons. You can open the article in a new tab instead.
No recent news available for EPIX.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for EPIX.
U.S. House Trading
No House trades found for EPIX.
Options Chain Settings
Changes apply instantly as you toggle. Tap Done when finished.
Bid/Ask/Mark (first):
Core Metrics:
More Greeks (optional):
Valuation:
Price & Momentum:
IV Variants:
IV Units:
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.
